Finance

Investor’s Alert: Weibo Corp (NASDAQ:WB), Kandi Technologies (NASDAQ:KNDI), Maxwell Technologies Inc. (NASDAQ:MXWL), Cytokinetics (NASDAQ:CYTK)

Weibo Corporation (ADR) (NASDAQ: WB) made its U.S debut last April 17 and was a major hit. Weibo commonly referred to as the Twitter (NYSE: TWTR) of China, opened at just below $17. Weibo Corp (ADR) (NASDAQ:WB) stock performance was 11.71% in last session and finished the day at $22.61. Traded volume was 13.46million shares in the last session and the average volume of the stock remained 32.09million shares.

Kandi Technologies Group Inc (NASDAQ:KNDI) which is a china based auto parts manufacturer announced on 14th April that progress has been made in its ongoing deliberations with Chinese government authorities to launch the “Public EV Sharing System Pilot Project”. Kandi Technologies Group Inc (NASDAQ:KNDI) rose 6.05 percent to $12.62 Monday on volume of 3.08million shares. The intra-day range of the stock was $11.85 to $13.06. Kandi Technologies Group Inc (NASDAQ:KNDI) has a market capitalization of $506.13million.

Maxwell Technologies, Inc. (NASDAQ:MXWL) announced that it is supplying ultracapacitors to ABB, the global leader in power and automation solutions, for ABB’s recent contract win to upgrade Philadelphia area rail lines. Maxwell Technologies Inc. (NASDAQ:MXWL)’s stock on Apr 21, 2014 reported a increase of 12.03% to the closing price of $15.83. Its fifty two weeks range is $5.02 -$16.15. The total market capitalization recorded $468.90million. The overall volume in the last trading session was 2.68million shares. In its share capital, MXWL has 29.62million outstanding shares.

Shares of Cytokinetics Inc (NASDAQ:CYTK) were the target of some unusual options trading activity on Monday. Stock investors purchased 2,901 put options on the stock, American Banking & Market News reports. This represents an increase of 222% compared to the typical volume of 902 put options. On Monday, shares of Cytokinetics, Inc. (NASDAQ:CYTK) advanced 13.45% to close the day at $10.80. Company return on investment (ROI) is -62.30% and its monthly performance is recorded as 9.53%. Cytokinetics, Inc. (NASDAQ:CYTK) quarterly revenue growth is 18.55%.